ÐлаÑник инÑелекÑÑалне ÑвоÑине 2012/04 - Ðавод за ...
ÐлаÑник инÑелекÑÑалне ÑвоÑине 2012/04 - Ðавод за ...
ÐлаÑник инÑелекÑÑалне ÑвоÑине 2012/04 - Ðавод за ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Гласник интелектуалне својине <strong>2012</strong>/4<br />
Intellectual Property Gazette <strong>2012</strong>/4<br />
(54) COMBINED TABLET FORM AND<br />
PROCEDURES FOR PRODUCTION THEREOF<br />
(57) Invention herewith described refers to the new form<br />
of combined tablets, containing four active components<br />
such as paracetamol from 35 to 45% w/w of the total<br />
tablet mass, propyphenazone from 25 to 37% w/w of the<br />
total tablet mass, codeine phosphate from 1.1 to 1.9%<br />
w/w of the total tablet mass and caffeine from 5 to 9%<br />
w/w of the total tablet mass as well as to the processes<br />
for the production thereof.<br />
(51) A 61 K 9/20 (2006.01)<br />
A 61 K 31/138 (2006.01)<br />
A 61 K 31/4422 (2006.01)<br />
(11) 2011/0136<br />
(13) A1<br />
(21) P-2011/0136 (22) 30.09.2009.<br />
(30) HU 30.09.2008. P0800591<br />
(86) WO 30.09.2009. PCT/HU2009/000085<br />
(87) WO 08.<strong>04</strong>.2010. WO 2010/038091<br />
(54) PREPARATI KOJI SADRŽE AMLODIPIN I<br />
BIZOPROLOL<br />
(71) EGIS GYÓGYSZERGYÁR NYILVÁNOSAN<br />
MŰKÖDŐ RÉSZVÉNYTÁRSASÁG, Keresztúri út. 30-<br />
38, H-1106 Budapest, HU<br />
(72) WAGNER, László, XI. utca 36, H-1172 Budapest,<br />
HU; ZSIG-MOND, Zsolt, Mátyás király u. 67, H-2234<br />
Maglód, HU; UJFALUSSY, György, Dózsa György u.<br />
13, H-1028 Budapest, HU; LEVENTISZNÉ, HUSZÁR,<br />
Magdolna, Virányos út 24/a, H-1125 Budapest, HU;<br />
TONKA-NAGY, Péter, Ököl u. 4/b 9, H-117l Budapest,<br />
HU; BÁR-CZAY, Erzsébet, Bökényföldi u. 23, H-1165<br />
Budapest, HU; GÓRA, Lászlóné, Gyöngyvirág u. 3, H-<br />
2117 Isaszeg, HU; SZELECZKI, Edit, Osztály u. 6-10/D<br />
1.2, H-1165 Budapest, HU; FÜLÖP, Ágnes, Szilágyi<br />
Dezső u. 87, H-1174 Budapest, HU<br />
(74) RISTIĆ, Dragoslav i MALEŠEVIĆ, Vladan,<br />
Cara Lazara 7, 11000 Beograd, RS<br />
(57) Predmetni pronalazak se odnosi na stabilni čvrsti<br />
farmaceutski preparat koji sadrži amlodipin ili njegove<br />
farmaceutski prihvatljive soli i bizoprolol ili njegove<br />
farmaceutski prihvatljive soli, kao i farmaceutski<br />
prihvatljive ekscipijense, upakovane u pakovanje<br />
nepropusno za vlagu, te koji dalje sadrži manje od 0, 5%<br />
jedinjenja sa formulom (3), u odnosu na masu aktivnih<br />
sastojaka.<br />
(54) COMPOSITIONS COMRRISING AMLODIPINE<br />
AND BISOPROLOL<br />
(57) Stable solid pharmaceutical composition containing<br />
amlodipine or pharmaceutical acceptable salts thereof<br />
and bisoprolol or pharmaceutical acceptable salts thereof<br />
as well as pharmaceutically accepted excipients,<br />
packaged in a damp- proof package and further<br />
comprising less than 0.5 % of the compound of the<br />
formula (3) based on the weight of the active ingredients.<br />
(51) A 61 K 9/20 (2006.01)<br />
A 61 K 31/485 (2006.01)<br />
A 61 K 9/00 (2006.01)<br />
(11) 2011/0564<br />
(13) A2<br />
(21) P-2011/0564 (22) 02.05.2002.<br />
(62) P-860/03<br />
(30) US 02.05.2001. 60/288,211<br />
(54) JEDNODNEVNE FORMULACIJE OKSIKODONA<br />
(71) EURO-CELTIQUE S.A., 2, Avenue Charles de Gaulle,<br />
1653 Luxembourg, LU<br />
(72) OSHLACK, Benjamin, 351 East 84th Street, New<br />
York, NY 10028, US; WRIGHT, Curtis, 1 Jarvis Street,<br />
Norwalk, CT 06851, US; PRATER, Derek, 28 Pearson<br />
Close, Milton, Cambridge, GB<br />
(74) JANKOVIĆ D.Ivan i ost., 11000 Beograd,<br />
Vlajkovićeva 28, RS<br />
(57) Pronalazak se odnosi na formulacije sa odloženim<br />
oslobađanjem koje sadrže oksikodon ili njegovu<br />
farmaceutski prihvatljivu so, koje obezbeđuje srednji<br />
C 24 /C max oksikodona od 0, 6 do 1, 0 ili 0, 7 do 1 posle<br />
davanja oralnim putem pri stabilnom stanju pacijentima i<br />
na postupke u vezi sa njima.<br />
(54) DIURNAL FORMULATION OF OXYCODONE<br />
(57) Invention herewith described refers to the delayed<br />
release formulations containing oxycodone or its<br />
pharmaceutically acceptable salt, which provides<br />
medium C 24 /C max of oxycodone from 0.6 to 1.0 or 0.7 to<br />
1 after administering orally in stable condition to patients<br />
and the procedures related thereto.<br />
(51) A 61 K 31/505 (2006.01)<br />
C 07 D 239/28 (2006.01)<br />
A 61 P 37/08 (2006.01)<br />
(11) <strong>2012</strong>/0098<br />
(13) A1<br />
(21) P-<strong>2012</strong>/0098 (22) 31.01.2003.<br />
(30) US 01.02.2002. 60/353333<br />
US 01.02.2002. 60/353267<br />
US 29.07.2002. 60/399673<br />
US 17.12.2002. 60/434277<br />
(86) 31.03.2003. PCT/US/2003/03022<br />
(87) 07.08.2003. WO 2003/063794<br />
(54) JEDINJENJA 2,4-PIRIMIDINDIAMINA I NJIHOVA<br />
UPOTREBA<br />
(71) RIGEL PHARMACEUTICALS INC, 1180 Veterans<br />
Boulevard, 94080 South San Francisco, CA, US<br />
A<br />
ЗИС / RS / IPO 1903